Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LAURUS LABS vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LAURUS LABS ZYDUS LIFESCIENCES LAURUS LABS /
ZYDUS LIFESCIENCES
 
P/E (TTM) x 105.5 34.2 308.1% View Chart
P/BV x 5.2 5.8 90.8% View Chart
Dividend Yield % 0.5 0.6 85.5%  

Financials

 LAURUS LABS    ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    LAURUS LABS
Mar-23
ZYDUS LIFESCIENCES
Mar-23
LAURUS LABS /
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs626495 126.5%   
Low Rs287319 89.8%   
Sales per share (Unadj.) Rs112.1170.3 65.9%  
Earnings per share (Unadj.) Rs14.819.8 74.8%  
Cash flow per share (Unadj.) Rs20.826.9 77.3%  
Dividends per share (Unadj.) Rs2.006.00 33.3%  
Avg Dividend yield %0.41.5 29.7%  
Book value per share (Unadj.) Rs74.7173.0 43.2%  
Shares outstanding (eoy) m538.651,012.20 53.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.12.4 170.2%   
Avg P/E ratio x30.920.6 149.9%  
P/CF ratio (eoy) x21.915.1 145.0%  
Price / Book Value ratio x6.12.4 259.5%  
Dividend payout %13.530.3 44.6%   
Avg Mkt Cap Rs m245,840412,144 59.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,57424,564 22.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m60,406172,374 35.0%  
Other income Rs m604,746 1.3%   
Total revenues Rs m60,466177,120 34.1%   
Gross profit Rs m15,92229,677 53.7%  
Depreciation Rs m3,2417,227 44.8%   
Interest Rs m1,6521,299 127.2%   
Profit before tax Rs m11,08925,897 42.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,1235,878 53.1%   
Profit after tax Rs m7,96620,019 39.8%  
Gross profit margin %26.417.2 153.1%  
Effective tax rate %28.222.7 124.1%   
Net profit margin %13.211.6 113.6%  
BALANCE SHEET DATA
Current assets Rs m34,617100,082 34.6%   
Current liabilities Rs m24,32355,267 44.0%   
Net working cap to sales %17.026.0 65.5%  
Current ratio x1.41.8 78.6%  
Inventory Days Days1450 28.8%  
Debtors Days Days1094 10.2%  
Net fixed assets Rs m41,987144,776 29.0%   
Share capital Rs m1,0771,012 106.5%   
"Free" reserves Rs m39,177174,146 22.5%   
Net worth Rs m40,255175,158 23.0%   
Long term debt Rs m7,6140-   
Total assets Rs m76,604244,940 31.3%  
Interest coverage x7.720.9 36.8%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.7 112.1%   
Return on assets %12.68.7 144.3%  
Return on equity %19.811.4 173.2%  
Return on capital %26.615.5 171.4%  
Exports to sales %039.2 0.0%   
Imports to sales %22.711.9 190.6%   
Exports (fob) Rs mNA67,577 0.0%   
Imports (cif) Rs m13,72020,544 66.8%   
Fx inflow Rs m43,47067,577 64.3%   
Fx outflow Rs m13,72020,544 66.8%   
Net fx Rs m29,75047,033 63.3%   
CASH FLOW
From Operations Rs m9,93926,888 37.0%  
From Investments Rs m-9,96111,712 -85.0%  
From Financial Activity Rs m-266-44,004 0.6%  
Net Cashflow Rs m-297-5,338 5.6%  

Share Holding

Indian Promoters % 27.2 75.0 36.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.5 18.0 202.6%  
FIIs % 25.4 5.0 508.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.8 25.0 291.0%  
Shareholders   382,880 306,495 124.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LAURUS LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on LAURUS LABS vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LAURUS LABS vs Cadila Healthcare Share Price Performance

Period LAURUS LABS Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.11% 0.57% 1.18%
1-Month -3.28% 7.77% -0.75%
1-Year 35.25% 107.52% 61.82%
3-Year CAGR 2.83% 32.30% 18.16%
5-Year CAGR 37.19% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the LAURUS LABS share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of LAURUS LABS hold a 27.2% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LAURUS LABS and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, LAURUS LABS paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 13.5%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of LAURUS LABS , and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.